The way accountable care organizations are set up makes them a perfect system of care for high-need, high-cost patients who might otherwise fall through the cracks of traditional delivery models, said Rob Mechanic, MBA, senior fellow at the Heller School of Social Policy and Management at Brandeis University and executive director of the Institute for Accountable Care.
The way accountable care organizations are set up makes them a perfect system of care for high-need, high-cost patients who might otherwise fall through the cracks of traditional delivery models, said Rob Mechanic, MBA, senior fellow at the Heller School of Social Policy and Management at Brandeis University and executive director of the Institute for Accountable Care.
Transcript
What is the role accountable care organizations can play in caring for high-need, high-cost patients?
First of all, the system is really failing high-need, high-costs patients. So, these are people who have complex illness, they’re frail, they’re socially isolated, they may have a lot of social factors that are affecting their health and their life, and they fall through the cracks of the traditional systems.
Now the ACOs, you really need a system of care to do the best that you can for these patients. They’re very expensive they are not only high utilizers but high utilizers of care that is avoidable care—a lot of unnecessary care—and so the ACO is our system of care. So, they’re well suited to try and fill those gaps.
The other issue is that a lot of the things that this population needs are not covered under traditional payment models or they’re under reimbursed. So, a home visit—physician visits at home, nurse visits at home—that don’t fit into the typical Medicare home healthcare visit. Other kinds of social supports—getting people appropriate food or helping them with housing. Those are things that aren’t paid for but in a global budget model, as in an ACO, there’s really more opportunity to be creative and do the right things for the patient and not just the things that Medicare will pay for. So, I think ACOs are very well positioned to help this group and it’s a real need in our system.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
EMBARK Data Show Continued Improvements With DMD Gene Therapy
March 19th 2025Data from the EMBARK trial of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) show that benefits in functional outcomes, gene expression, and muscle imaging persist 2 years after receiving the gene therapy.
Read More
How Access to SMA Treatment Varies Globally and by Insurance Type
March 18th 2025Posters presented at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference show that therapeutic advances in treating spinal muscular atrophy (SMA) are not uniformly making it into the hands of patients who could benefit.
Read More